Spyre Therapeutics Inc (SYRE)

Net Change in Cash

$80.35M

TTM · Period ending: · USD

SYRE logo

SYRE Net Change in Cash

Latest reported$80.35M
SYRE TTM Net Change in Cash (-$1.98M → $80.35M)
High-resolution chart · PNG

SYRE net change in cash history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Spyre Therapeutics Inc Net Change in Cash — Trailing twelve months (TTM) (USD)
Period endingNet Change in Cash (USD)
80,348,000
48,692,000
-3,702,000
-6,683,000
36,194,000
-179,380,000
-99,794,000
-20,321,000
-191,212,000
191,318,000
152,799,000
51,381,000
197,401,000
20,088,000
19,436,000
14,016,000
2,663,000
-65,611,000
-74,957,000
-29,221,000
-30,602,000
67,982,000
71,184,000
29,678,000
40,283,000
-71,551,000
-1,708,000
11,513,000
6,351,000
74,885,000
9,644,000
1,370,000
-6,355,000
-6,041,000
-34,931,000
-36,382,000
-43,694,000
-7,215,000
18,454,000
18,704,000
31,547,000
-19,775,000
26,678,000
25,138,000
37,079,000
40,567,000
-1,981,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.